State Street’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

State Street’s Portfolio CRXT Stock Details CRXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,536	Closed	-$10K	–	4991
2022 Q2	$10K	Buy	+25,536	New	+$17.9K	﹤0.01%	4925

Other funds holding CRXT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

State Street's CRXT Position: Q3 2022 in Review

State Street sold out of Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) in Q3 2022, closing a stake of 25,536 shares — an estimated $10K sold.

State Street first reported a position in CRXT in Q2 2022 and held it in 1 quarter. The position peaked at $10K in Q2 2022. 2 funds tracked by Wall St. Rank hold CRXT as of Q3 2022.

State Street reported no remaining Clarus Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
State Street sold 25,536 Clarus Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $10K.
State Street first reported a position in Clarus Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
State Street's Clarus Therapeutics Holdings, Inc. Common Stock position peaked at $10K in Q2 2022.
2 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.